Navigation Links
MCG receives second-time designation from National Cancer Institute
Date:12/20/2007

The Medical College of Georgia has again been designated by the National Cancer Institute as a Minority-Based Community Clinical Oncology Program.

The renewal, which comes with a five-year $2.3 million grant, provides more access to the latest cancer treatment and prevention strategies for all cancer patients, particularly minorities, says Dr. Anand Jillella, chief of the MCG section of Hematology/Oncology and principal investigator on the grant.

The real advantage of the grant is that it is minority-based, which is really relevant here because we have such a significant number of minority patients, says Dr. Kapil N. Bhalla, director of the Medical College of Georgia Cancer Center. The National Cancer Institute recognizes the need to extend studies and clinical trials to those populations and this grant enables us to help advance that initiative by supporting the work done by cancer researchers and clinicians here. This type of work is integral to the overall mission of the Cancer Center - to facilitate and inspire cancer research. It is the perfect marriage of our clinical and research components.

MCG, eligible because more than 40 percent of its newly-diagnosed patients and 40 percent of patients enrolled in clinical trials are minorities, first received the designation in 2004.

The Veterans Affairs Medical Center in Augusta, Aiken Regional Medical Center in Aiken, S.C., and Athens Regional Medical Center in Athens, Ga., are collaborators on the grant.

Dr. Daron G. Ferris, family medicine physician and director of the Gynecologic Cancer Prevention Center at MCG, and Dr. Roger A. Vega, chief of the MCG Section of Pediatric Hematology/Oncology are co-principal investigators.

This designation allows us to continue to broaden the scope of clinical trials and prevention programs by providing support for the infrastructure those initiatives require, Dr. Jillella says.

Unlike the typical grant, program funding supports the infrastructure for dozens of clinical studies instead of just one, says Dr. Jillella.

Before this grant, providing trials was difficult because we could not support the personnel needed for that, he says. Because of the CCOP, we can hire the personnel we need, including research nurses, study coordinators and administrative assistants who are all an important part of clinical research activity.

The grant also allows for collaborative work between adult, preventive and pediatric cancer researchers and clinicians.

One particular way that we have and will continue to benefit from this grant is in the increasing collaboration between adult and pediatric oncology, says Dr. Vega. Having this grant as the common denominator allows us to share. There is a lot that both sides can learn from each other.

For example, he says, young adults who are diagnosed with cancer often fall in the middle between adult and pediatric oncology. While pediatricians treat patients until age 21, many pediatric trials do not apply to those older patients.

Because of the CCOP cooperation, we can extend adult trials to our pediatric patients that wouldnt have been available before, he says.

The grant also provides money for studies on preventing cancer and studies that can help improve the quality of life for patients already undergoing treatments.

Theres a lot of research being done on potential treatments, but theres only a drop in the bucket of studies that focus on the patient with cancer, says Dr. Ferris. When people have cancer, clearly, one of the major goals is to cure it. But we also realize that during that process, some bad things can happen. Thats where we come in. We need to find ways to minimize suffering and make the treatment period more tolerable for the patient. Are there better medications" Alternative treatments for side effects of drugs"

These types of studies also help patients take an active part in their cancer, which gives them hope for themselves, their friends and their families.


'/>"/>

Contact: Jennifer Hilliard
jhilliard@mcg.edu
706-721-8604
Medical College of Georgia  
Source:Eurekalert

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MCG receives second-time designation from National Cancer Institute
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... proudly announces the launch of its 60-day free trial program for all of ... shipping make the offer a truly hassle free experience. , FlexiSpot’s unique desktop ...
(Date:12/2/2016)... ... 02, 2016 , ... With the number of pain management programs available for ... find the one that works for them. When an inventor from Suisun City, Calif., ... and decided to share it with others. , He developed a prototype for PRO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to ... which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping ... prolonging life 6 years in the last 3 decades,” says Dr. Valentine Fuster, ...
(Date:12/2/2016)... ... , ... Sourced from the Isbre Springs beneath the 5,000 year old Hardanger ... of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent taste ... several ShopRite and FoodTown stores in NJ and received rave comments from consumers. , ...
(Date:12/2/2016)... Francisco, CA (PRWEB) , ... December 02, 2016 ... ... digitally-enabled care journeys, announced today that it has raised $6.0 million in an ... inspired by Clarify Health’s conviction that patients and their caregivers can receive far ...
Breaking Medicine News(10 mins):
(Date:11/30/2016)... Nov 30, 2016 Research and Markets has ... Monitoring Devices 2017 - MedCore" report to their offering. ... , , ... the skull. In healthy individuals, it is circulated though the brain and ... where the amount of CSF surrounding the brain changes significantly. ...
(Date:11/30/2016)... Research and Markets has announced the addition of the ... their offering. ... Detachable coil embolization is a minimally invasive method ... embolization treatment of cerebral aneurysms is less invasive and requires less recovery ... wall of an artery in the brain. This area bulges in the ...
(Date:11/30/2016)... Calif. , Nov. 30, 2016 Varian ... it was named America,s Most JUST Company in the ... and Forbes magazine,s inaugural "JUST 100 List." ... of the largest surveys ever conducted on attitudes towards ... months. This inaugural list ranks U.S companies against their ...
Breaking Medicine Technology: